Depressive Disorder: all 4,847 studies
Page 48 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Expanding and Testing VA Collaborative Care Models for DepressionWithdrawnNCT00119028Not applicable
- Parent Psychoeducation and Cognitive Behavior Therapy for Latino Adolescents With DepressionStatus unknownNCT00118469Phase 2
- Dopamine Receptor Imaging in Mood DisordersCompletedNCT00116077
- Comparison of Escitalopram Combination in Adult Patients With Major Depressive DisorderCompletedNCT00109044Phase 3
- Study of Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00108979Phase 3
- VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C PatientsCompletedNCT00108563Phase 4
- Study Comparing Two Types of Psychotherapy for Treating Depression and Substance AbuseCompletedNCT00108407Not applicable
- Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With DepressionStatus unknownNCT00106197Phase 4
- A Cognitive-Behavioral Intervention for Depression and Anxiety in COPDCompletedNCT00105911Not applicable
- Evaluation Study of TIDES Depression Care Quality Improvement InterventionCompletedNCT00105820Not applicable
- TEAM Study to Improve Depression Care in Rural CBOCsCompletedNCT00105690Not applicable
- Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive DisorderCompletedNCT00104611Phase 3
- Trial Investigating the Effect of Different Exercise Forms on DepressionStatus unknownNCT00103415Not applicable
- Study Of GW679769 In Major Depressive DisorderCompletedNCT00102492Phase 2
- Teen Depression Awareness Project (TDAP)CompletedNCT00099827Phase 1
- Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood DisordersCompletedNCT00097175
- Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major DepressionCompletedNCT00096798Phase 3
- Cognitive Behavioral Therapy for Early-Onset DepressionCompletedNCT00096642Not applicable
- A Long-Term Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00095745Phase 3
- Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard TherapyCompletedNCT00095134Phase 3
- Major Depressive Disorder In The ElderlyCompletedNCT00093288Phase 3
- Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
- Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
- Yoga for Treating People at Risk for Diabetes or With Both HIV and DepressionCompletedNCT00090506Phase 1
- Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
- Neurocardiac Control in Major DepressionCompletedNCT00084162
- Function of Catecholamines in the Brain During DepressionCompletedNCT00082030
- FMRI Study of Performance During a Probabilistic Reversal Learning Task in DepressionCompletedNCT00075296
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
- Reducing Symptoms of Depression in Low-Income MothersCompletedNCT00074789Phase 2
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
- Treatment of Depression in AdultsCompletedNCT00073697Phase 4
- Prevention of Depression in At-Risk AdolescentsCompletedNCT00073671Not applicable
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Effects of Therapist Behavior on the Treatment of Depressed AdolescentsCompletedNCT00073359Phase 1/2
- A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive DisorderCompletedNCT00073203Phase 2
- Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
- Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical TrialApproved for marketingNCT00071708
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4
- Preventing Post-Stroke DepressionCompletedNCT00071643Not applicable
- Evaluating Brain Responses to Facial Expressions in Major Depressive DisorderCompletedNCT00071123
- An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant DepressionCompletedNCT00070694Phase 2
- Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and DepressionTerminatedNCT00069927Phase 2
- Seasonal Affective Depression (SAD) StudyCompletedNCT00069459Phase 1
- Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major DepressionCompletedNCT00069407Not applicable
- Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
- Depression Study In Elderly PatientsCompletedNCT00067444Phase 3
- PUFA Augmentation in Treatment of Major DepressionCompletedNCT00067301Phase 3
- Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating DepressionCompletedNCT00066859Phase 3
- Lethargic Depression StudyCompletedNCT00064467Phase 3
- Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3
- Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
- The Effects of Estrogen Withdrawal on Mood Symptoms in WomenCompletedNCT00060736
- Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCompletedNCT00060489Phase 3
- Brain Regulation of Emotions in People With Depression and AnhedoniaCompletedNCT00059579
- Improving Retention of Hispanics Receiving Antidepressant TherapyCompletedNCT00057642Not applicable
- Outreach and Treatment for Depression in the Labor ForceCompletedNCT00057590Not applicable
- An 8 Week Depression Study In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057239Phase 2
- An 8 Week Study Of Adults Diagnosed With Major Depressive DisorderCompletedNCT00057226Phase 2
- An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057213Phase 2
- Screening Evaluation for Women With Postpartum DepressionTerminatedNCT00056901
- Treatment of Depression in Nursing HomesCompletedNCT00056485Not applicable
- Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging StudiesTerminatedNCT00055575Phase 2
- Prevention of Postpartum Depression in Low-Income WomenCompletedNCT00053651Phase 1
- Effects Of Antidepressants On Sexual Functioning In AdultsCompletedNCT00051272Phase 3
- Effects of Antidepressants on Sexual FunctioningCompletedNCT00051259Phase 3
- Group Therapy for Postpartum DepressionCompletedNCT00051246Not applicable
- Therapy for Depression With Co-occurring Panic or Anxiety SymptomsCompletedNCT00051207Phase 1/2
- Brain Imaging in DepressionCompletedNCT00050700
- Major Depressive Disorder Study In AdultsCompletedNCT00049972Phase 4
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)CompletedNCT00048607Phase 3
- Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)CompletedNCT00048594Phase 3
- A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive DisorderCompletedNCT00048204Phase 2
- MRI Study of Brain Activity and Risk for Depression in AdolescentsCompletedNCT00047944
- Study Evaluating Venlafaxine ER in Recurrent DepressionCompletedNCT00046020Phase 4
- Optimizing Electroconvulsive Therapy for DepressionCompletedNCT00045916Phase 4
- Treatment Outcome of Vascular DepressionCompletedNCT00045773
- Magnetic Stimulation Therapy for Treating Vascular DepressionCompletedNCT00044798Phase 3
- A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant DepressionCompletedNCT00044681Phase 3
- Clinician Managed Interpersonal PsychotherapyCompletedNCT00043602Early Phase 1
- Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
- Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
- Examination of a Soy-Based Supplement for Major DepressionCompletedNCT00042380Phase 2
- Preventing Depression in Patients With Macular DegenerationCompletedNCT00042211Phase 3
- Treatment of Depression After Coronary Bypass SurgeryCompletedNCT00042198Not applicable
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)CompletedNCT00042029Phase 3
- Clinical Trial of Memantine for Major DepressionCompletedNCT00040261Phase 3
- Major Depression and Inflammatory Risk Markers for Coronary Heart DiseaseCompletedNCT00037505
- Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
- Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)CompletedNCT00035295Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)CompletedNCT00035282Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)CompletedNCT00035048Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)CompletedNCT00035009Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)CompletedNCT00034983Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)CompletedNCT00034944Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
- Clinical Trial of Felbamate for Treatment-Resistant Bipolar DepressionCompletedNCT00034229Phase 2